Charles Schwab Investment Management »

Trevi Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $144k 108k 1.34
2023-09-30 $235k 108k 2.18
2023-06-30 $257k 108k 2.39
2023-03-31 $23k 13k 1.85
2022-12-31 $24k 13k 1.93
2022-09-30 $20k 13k 1.59
2022-06-30 $36k 13k 2.87